| Sinocro Partners is a US merchant bank specialized in China healthcare
and life science industry related investments and advisories. Sinocro
partners provides advisory services in the area of china related
investment, strategy, business development, government relationship,
sale and marketing for both investment institutions and global life
science industry leaders. Sinocro Partners has strong connections
and execution capabilities of providing service related to medical
affairs, preclinical and clinical developments, and research and
discovery projects in China. Sinocro Partners also invest into life
science companies and provide financial advisory related to fund
raisings, and oversea IPOs.
Sinocro��s management team also has a unique combination of former
high-level Chinese government officials, US consultants, US bankers,
as well as Chinese industry leaders. Our combined business experiences
from Pfizer, Mckinsey, Boston Consulting Group, Credit Suisse
First Boston allow us to make the best judgments and advice for
our clients.
Sinocro has formed broad partnerships with major research institution,
biotech companies, and top Chinese pharmaceutical and biotech
companies. Sinocro can help our client leverage the current existing
manufacture, R&D, and sale and marketing coverage of state
enterprise and local companies, and minimize upfront fix asset
investment and operation cost.
|
